All In MedTech

Device Trial Radar · NCT05229445

A Continuous Glucose Monitor Based Insulin Bolus Calculator

Safety of a Real-time Continuous Glucose Monitor-based Insulin Bolus Calculator: The "CGM-IBC" Study

Last checked: Nov 20, 2026Latest source record: Oct 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

27

Actual

Start

Jul 5, 2022

Primary completion

Sep 28, 2022

Study completion Sep 28, 2022

Sponsor

Lead sponsor
WelldocNot on our public-company list
Sponsor type
Industry
First posted
Feb 8, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor

Conditions

  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1

Interventions

  • continuous glucose monitor based insulin bolus calculatorDevice

    Participants will use the bolus calculator with meals to calculate their insulin bolus doses

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. time in rangeTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Northwestern University

    Chicago, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.